Castle Creek Arbitrage’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Castle Creek Arbitrage’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-126,723	Closed	-$1.24K	–	566
2022 Q4	$1.24K	Hold	126,723	–	–	﹤0.01%	503
2022 Q3	$11K	Hold	126,723	–	–	﹤0.01%	546
2022 Q2	$9K	Hold	126,723	–	–	﹤0.01%	592
2022 Q1	$23K	Hold	126,723	–	–	﹤0.01%	597
2021 Q4	$68K	Hold	126,723	–	–	﹤0.01%	575
2021 Q3	$73K	Buy	+126,723	New	+$85.1K	﹤0.01%	526

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Castle Creek Arbitrage's IBER.WS Position: Q1 2023 in Review

Castle Creek Arbitrage sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 126,723 shares — an estimated $1.24K sold.

Castle Creek Arbitrage first reported a position in IBER.WS in Q3 2021 and held it in 6 quarters. The position peaked at $73K in Q3 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Castle Creek Arbitrage reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 126,723 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $1.24K.
Castle Creek Arbitrage first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q3 2021 and held it in 6 quarters.
Castle Creek Arbitrage's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $73K in Q3 2021.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Castle Creek Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.